NSE · ACUTAAS.NS
Acutaas Chemicals Limited
₹4,007.70+₹31.00 (+0.78%)
Acutaas Chemicals Limited’s quoted price sits in the upper half of its reported 52-week range, 0.61% below the high.
Loading market information…
NSE · JUBLINGREA.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Jubilant Ingrevia Limited’s quoted price sits in the lower half of its reported 52-week range, 29.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jubilant Ingrevia Limited’s forward annual dividend is ₹5.00 per share, paid semi-annual. The forward yield is 0.89% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Jubilant Ingrevia Limited’s next earnings report is currently expected on Feb 2, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jubilant Ingrevia Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jubilant Ingrevia Limited, established in 2019 and based in Noida, India, is a global supplier of life science products and comprehensive solutions. The company's operations are divided into three core divisions: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment delivers a variety of specialized ingredients, fine chemicals, and crop protection agents, in addition to offering custom development and manufacturing (CDMO) services. Its Nutrition & Health Solutions division focuses on ingredients for both human and animal nutrition and well-being. Meanwhile, the Life Science Chemicals segment provides crucial life science components and a range of specialized ethanol products. Jubilant Ingrevia's extensive portfolio encompasses numerous chemical offerings, including a broad spectrum of pyridine derivatives (such as picolines, cyanopyridines, and various substituted pyridines), essential vitamins like B3 and riboflavin phosphate sodium, and nutritional compounds like premixes and antioxidants. They also produce industrial chemicals like acetic anhydride, ethyl acetate, and various alcohols (absolute alcohol, ethanol), alongside biocompost and gas mixtures. Furthermore, the company supplies a wide array of animal health and nutrition additives, including mineral premixes, stress regulators, amino acids, herbal growth promoters, toxin binders, and enzymes. Beyond its product range, Jubilant Ingrevia offers specialized services in chemical synthesis, covering everything from initial route design and process optimization to scaling up production and commercial manufacturing of intermediates. The company serves a diverse client base across the pharmaceutical, nutrition, agrochemical, consumer goods, and industrial sectors. Originally incorporated as Jubilant LSI Limited, the company adopted its current name, Jubilant Ingrevia Limited, in October 2020.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:52 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2026 |
|---|
| Jul 31, 2025 |
| ₹4.80+6.67% vs estimate |
| ₹10.38B-0.06% vs estimate |
| Q4 2025 | May 13, 2025 | ₹4.64 | ₹10.38B+0.27% vs estimate |
|---|
| Q3 2025 | Jan 28, 2025 | ₹4.39+119.5% vs estimate | ₹10.46B+2.11% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹4,007.70+₹31.00 (+0.78%)
Acutaas Chemicals Limited’s quoted price sits in the upper half of its reported 52-week range, 0.61% below the high.
₹5,034.00-₹112.00 (-2.18%)
Atul Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.89% below the high.
₹3,055.00-₹109.20 (-3.45%)
BASF India Limited’s quoted price sits in the lower half of its reported 52-week range, 33.0% below the high.
₹3,275.00-₹21.30 (-0.65%)
Privi Speciality Chemicals Limited’s quoted price sits in the upper half of its reported 52-week range, 13.48% below the high.
₹986.00-₹52.60 (-5.06%)
Vinati Organics Limited’s quoted price sits in the lower half of its reported 52-week range, 42.14% below the high.
₹152.40-₹7.57 (-4.73%)
Laxmi Organic Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 25.22% below the high.
₹1,650.00+₹35.20 (+2.18%)
Tatva Chintan Pharma Chem Limited’s quoted price sits in the upper half of its reported 52-week range, 21.93% below the high.
₹3,184.00-₹253.60 (-7.38%)
Yasho Industries Limited’s quoted price sits in the upper half of its reported 52-week range, 36.24% below the high.
